This article sheds light on Type 2 diabetes, and the importance of holistic management and culturally competent care.​ ...

Researchers at Pennington Biomedical Research Center have revealed critical insights into how impaired mitochondrial dynamics ...

Beware! Do not add these 7 dangerously high sugar content summer superfoods to your diet when you have diabetes - they can ...

Researchers at Thomas Jefferson University have found a new way to help. Their study showed that using two diabetes ...

SGLT2 inhibitors and GLP-1 agonists are class 1 medications, but many Medicaid patients have challenges with access.

Stonestreet was diagnosed with type 2 diabetes in 2009, but kept it a secret. He told Business Insider why he's speaking out ...

Endogenex said the study "demonstrates substantial and durable reduction in insulin resistance and improvement in beta cell ...

A study involving Schulich prof Dr. Tamara Spaic combined glucose monitoring and an automated insulin pump for Type 2 ...

The SOUL trial showed that oral semaglutide was safe in patients with type 2 diabetes and atherosclerotic cardiovascular ...

SGLT-2 inhibitor use vs DPP-4 inhibitor use was associated with lower incidence of epilepsy among patients with type 2 diabetes.

Italy: A recent multicentre real-world study supports the long-term effectiveness of once-weekly semaglutide as a valuable ...